Categories: HealthcareNews

Editas Medicine Announces Upcoming Investor Events

CAMBRIDGE, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that management will participate in the following upcoming investor conferences:

  • 2023 Wells Fargo Healthcare Conference
    Format: Fireside Chat
    Date: Thursday, September 7
    Time: 3:00 p.m. ET
    Location: Boston, MA
  • Morgan Stanley 21st Annual Global Healthcare Conference
    Format: Fireside Chat
    Date: Monday, September 11
    Time: 10:00 a.m. ET
    Location: New York, NY
  • Cantor Global Healthcare Conference 2023
    Format: Fireside Chat
    Date: Tuesday, September 26
    Time: 1:35 p.m. ET
    Location: New York, NY

To access the live webcasts of Editas Medicine’s presentations, please visit the “Investors” section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following each event.

About Editas Medicine
As a clinical-stage genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute’s Cas12a patent estate and Broad Institute and Harvard University’s Cas9 patent estates for human medicines. For the latest information and scientific presentations, please visit www.editasmedicine.com.

CONTACT: Media and Investor Contact:
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

Staff

Recent Posts

Sonendo Strengthens Leadership With Key Strategic Appointments

John Bostjancic Appointed as Chief Financial Officer Bob Guyatt Appointed as Senior Vice President of…

2 hours ago

ACSD Granted Significant Telemedicine Patent

IRVINE, Calif., June 5, 2024 /PRNewswire/ -- ACS Diagnostics, Inc. of Irvine CA, with executive…

2 hours ago

Neogen® to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

LANSING, Mich., June 5, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG), an innovative leader in…

2 hours ago

Alleva Shines at the West Coast Symposium on Addictive Disorders

Leading Behavioral Health Practice Management Platform Showcases Innovation and Care at Premier Industry Event PALM…

2 hours ago

BRIJ Medical Launches Brijjit BP-75: Precision Technology for Smaller Surgical Incisions

MARIETTA, Ga., June 5, 2024 /PRNewswire/ -- BRIJ Medical, a medical device company revolutionizing surgical…

2 hours ago

Activated Insights Powers Majority of Award-Winning Communities in 2024 U.S. News Best Senior Living Ratings

REXBURG, Idaho, June 5, 2024 /PRNewswire/ -- Activated Insights, an HCP company, has played a pivotal…

2 hours ago